ContractBRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma20-Sep-2024 / 19:47 CET/CESTDisclosure of ...
Some results have been hidden because they may be inaccessible to you